IP Library Granted Patent US 9,399,800
Granted Patent B2
US 9,399,800 · App. 14/827,013 · Granted Jul 26, 2016

Detecting neoplasm

Inventors: William R. Taylor (Lake City, MN); Jonathan J. Harrington (Madison, WI); Patrick S. Quint (Kasson, MN); Hongzhi Zou (Middleton, WI); Harold R. Bergen, III (Spring Valley, MN); David I. Smith (Rochester, MN); David A. Ahlquist (Rochester, MN)
Assignee: Mayo Foundation for Medical Education and Research
C12Q1/6886C12Q1/37C12Q1/40G01N33/57407G01N33/57419G01N33/57438C12Q2600/154C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,399,800
App. No.
14/827,013
Granted
Jul 26, 2016
Kind
B2
Abstract

This document relates to methods and materials for detecting premalignant and malignant neoplasms. For example, methods and materials for determining whether or not a stool sample from a mammal contains nucleic acid markers or polypeptide markers of a neoplasm are provided.

Claims (14)

1. A system for detecting colorectal cancer or pre-cancer in a mammal, said system comprising:

a) a stool sample,

b) reagents sufficient for measuring a K-ras mutation score within said stool sample, wherein said reagents comprise K-ras specific primers, and

c) reagents sufficient for converting unmethylated cytosine residues to uracil residues within said stool sample while leaving 5-methylcytosine residues unchanged, wherein said reagents sufficient for converting unmethylated cytosine residues to uracil residues within said stool sample while leaving 5-methylcytosine residues unchanged comprise a bisulfite reagent, and reagents sufficient for measuring BMP3 methylation within said stool sample, wherein said reagents sufficient for measuring BMP3 methylation comprise BMP3 specific primers and a bisulfite reagent.

2. The system of claim 1 , further comprising a DNA stabilization buffer.

3. The system of claim 1 , further comprising DNA extraction reagents.

4. The system of claim 1 , wherein said reagents for measuring a K-ras mutation score within said stool sample comprise reagents for conducting a digital melt curve analysis.

5. The system of claim 1 , wherein said reagents for measuring a K-ras mutation score within said stool sample comprise reagents for conducting quantitative allele-specific PCR.

6. The system of claim 1 , wherein said reagents for measuring BMP3 methylation within said stool sample comprise reagents for conducing real-time methylation-specific PCR.

7. The system of claim 1 , wherein said K-ras specific primers comprise a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 2, 3, 4, 5, 6 and 7.

8. The system of claim 1 , wherein said reagents sufficient for measuring a K-ras mutation score within said stool sample further comprise one or more K-ras specific probes.

9. The system of claim 8 , wherein said one or more K-ras specific probes comprise SEQ ID NO: 1.

10. The system of claim 1 , further comprising a stool stability buffer comprising Tris pH 9.0, EDTA, and NaCl.

11. The system of claim 1 , wherein the bisulfite reagent is sodium bisulfite.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: TAYLOR, WILLIAM R.; HARRINGTON, JONATHAN J.; QUINT, PATRICK S.; ZOU, HONGZHI; BERGEN, HAROLD R., III; SMITH, DAVID I.; AHLQUIST, DAVID A.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 036336/0813 →
Continuity (4)
Continuation 14168552 · Jan 30, 2014
Continuation 12866558
Provisional Application 61029221 · Feb 15, 2008
Related Publication 20150354013A1 · Dec 10, 2015